Talphera Inc (FRA:R5XA)
€ 0.582 0 (0%) Market Cap: 8.66 Mil Enterprise Value: -1.23 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 39/100

AcelRx Pharmaceuticals Inc To Host KOL Event Transcript

Dec 06, 2023 / 04:00PM GMT
Release Date Price: €0.769 (+2.67%)
Operator

Both are important, sorry. No, no, no, some book but the book in many cases, meaning making this we've been in this we may be making this. We'll move in Good afternoon and welcome to the Excel Rx KOL panel discussion. And at this time, all participants are in a listen only mode, a Q&A session will follow the formal presentations and panel discussion. As a reminder, this event is being recorded and a replay will be made available on the XL Rx website following the conclusion of the event. I would now like to turn the call over to your host, Dr. Pamela Palmer, Chief Medical Officer, and Co-Founder of Accelerate. Please go ahead, Dr.

Pam Palmer
AcelRx Pharmaceuticals, Inc. - Chief Medical Officer and Co-Founder

Thank you, Sarah. We're super excited today for our KOL panel discussion. The topic is the anticoagulation market for dialysis and update on our NIOBE registrational study, and we may be making forward-looking statements and please refer to our SEC filings regarding those. Our agenda for today is an introduction to our panelists and to the product Nayak

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot